NEW YORK (GenomeWeb) – CareDx today announced that two Medicare Administrative Carrier jurisdictions have issued positive decisions on covering its AlloMap molecular diagnostic surveillance test for heart transplant patients, extending coverage to Medicare patients in 11 additional states.

Four of the 12 MAC jurisdictions now cover the test. The newly affected states are Ohio, Kentucky, Oregon, Washington, Arizona, Utah, Idaho, Montana, North Dakota, South Dakota, and Wyoming.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.